TickerFacts.

NovaBridge Biosciences (NBP): Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Revenue is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

27.64M CNY
Year ended 2023-12-31
-73.8%
3-year compound annual growth
-12.5%
5-year compound annual growth
1.54B CNY2017-12-31: 11.56M CNY2018-12-31: 53.78M CNY2019-12-31: 30.00M CNY2020-12-31: 1.54B CNY2021-12-31: 88.03M CNY2022-12-31: -221.56M CNY2023-12-31: 27.64M CNY27.64M CNY
2017-12-31 Revenue (CNY) 2023-12-31
Period endedRevenueChange YoYSource filing
2023-12-3127.64M CNYn/m2024-04-30, From 2023-01-01
2022-12-31-221.56M CNYn/m2024-04-30, From 2022-01-01
2021-12-3188.03M CNY-94.3%2024-04-30, From 2021-01-01
2020-12-311.54B CNYn/m2023-05-01, From 2020-01-01
2019-12-3130.00M CNY-44.2%2022-04-29, From 2019-01-01
2018-12-3153.78M CNY+365.4%2021-04-28, From 2018-01-01
2017-12-3111.56M CNYn/a2020-04-29, From 2017-01-01